FDA Investigator Felipe Rde Almeida
Felipe Rde Almeida has conducted inspections on 72 sites in 2 countries as of 04 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
72
Last Inspection Date:
04 Jun 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America,
Italy
FDA Investigators that have inspected at least one site in common with Felipe Rde Almeida:
Alan Escalona,
Alec M O'neal,
Allison C Hunter,
Allison E Sincek,
Allison M Scheck,
Amanda M Osteen,
Andrew I Carr,
Andrew M Kupper,
Andrew T Todd,
Andria L Kuhlman,
Anna M Brannen,
Annemarie Kleiza,
Ariel J Cutchins,
Bailey A Uetrecht,
Benjamin D Motsinger,
Benjamin D Shuler,
Brian J Ryan,
Brian R Yaun,
Brigitte K Hofmann,
Burnsb,
Carlos H Ruiz,
Cathleen A Carr Sharpe,
Chris B Dedic, RS,
Christian L Witkovskie,
Christina L Bigham,
Craig P Seaborn,
Craig T Rybus,
Daisy E Ramos,
Davis,
Diane R Mcdaniel,
Elizabeth Ll Edwards,
Eric R Holm,
Erica N Sandoval,
Greg K Keshishyan,
Gretchen N Kilby,
Holly J Wilson,
James G Marsh,
Jamie L Johnson,
Jason D Werne,
Jason R Vidaurrie,
Javonica F Penn,
Jennifer A Downie,
Jennifer A Pruden,
Jessica M Wooten,
John D Jaworski,
John E Russell, Jr,
Jonathan A Ferguson,
Jonathan D Horn,
Joshua S Hunt,
Judy C Nepsa,
Karen M Cooper,
Kathleen D Culver,
Kathryn J Mccarty,
Kelli L Wilkinson,
Kevin Lee,
Kimberly M Lichter,
Kirk A Dymbrowski,
Kirk W Gaston,
Krista S Tuggle,
Krista T Ferry,
Lauren R Collins,
LCDR Matthew R Mcnew, MPH, REHS/RS,
Lindsey M Schwierjohann,
Luckner Jean Marie,
Marianne Allen,
Maribeth G Niesen,
Mark E Parmon,
Mary E Ferren,
Matt D Suedkamp,
Meredith M Cobb,
Michael K Larson,
Michael P Sheehan,
Nicholas L Paulin,
Pifer,
Raquel L Coleman,
Robert P Neligan,
Robert W Hudson,
Siobhan G Taylor,
Stephen G Mclane,
Steven P Eastham,
Susan M Taylor,
Takiyah S Gilmore Embery,
Talmane J Fisher,
Tamara M Kays,
Teresa K Kastner,
Thomas B Smith,
Thomas C Woods,
Thomas J Prigge,
Tracey L Harris,
Troy A Huffman
Felipe Rde Almeida's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2022 | FDA 483 | J.M. Smucker LLC - Form 483, 2022-07-06 |
February, 2019 | EIR | Quality Bakery Facility, Division of T. Marzetti Company - EIR, 2019-02-15 |
February, 2019 | FDA 483 | Quality Bakery Facility, Division of T. Marzetti Company - Form 483, 2019-02-15 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more